全球医疗器械公司与Medtech的Medtech型号为基于领先的云的收入管理系统。亚愽申请

加利福尼亚州圣马特奥。2019年2月14日 -亚愽申请Model N，Inc。（纽约证券交易所代码：Modn），基于云的收入管理解决方案的领导者今天宣布它与ICU Medical（纳斯达克：ICUI）合作，在制定，制造和销售医疗设备的全球领导者 - 现代化和结合company’s legacy revenue systems in the cloud with Model N Revenue Cloud for MedTech.

The implementation of Model N’s revenue management solution was part of ICU Medical’s strategic worldwide initiative to consolidate their manufacturing and distribution centers and implement new quoting and sales compensation systems following the acquisition of the Hospira Infusion Systems business from Pfizer in 2017. The global revenue cloud implementation required the conversion of master data, contracts, and historical transactions and reports from three legacy systems: Hospira, ICU U.S., and ICU Canada.

“Model N’s revenue management solution is getting very positive feedback from both legacy Hospira users as well as new ICU Medical users,” said Mark Anderson, SVP Global Services at Model N. “With the tremendous growth in this industry—led by an aging population reliant on the care provided by advanced medical devices—we’re happy to be at the forefront of providing cloud solutions to ease the challenges these companies face.”

根据2018 - 2018年12月，全球医疗设备和技术市场将在2018 - 2018年12月期间增长1.19亿美元，在2018年至2018年12月期间增长了11.9亿美元报告。像ICU医疗等公司正在寻求解决方案，以帮助他们获得能见度，并确保监管遵守更有效地管理和最大化其日益增长的收入。

关于模型n：亚愽申请亚愽申请Model N是生命科学云收入管理解决方案的领先提供商高科技公司。推动关键任务业务流程，如定价，引用，承包，法规遵从性，折扣和激励，我们的软件帮助公司知道并增长其真实的顶线并以速度和规模最大限度地提高每个收入时刻。With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in pharmaceutical, medical technology, semiconductor, and high-tech manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor. For more information, visitwww.shabbele.com.。

关于ICU医疗：ICU Medical，Inc。（纳斯达克：ICUI）开发，制造和销售用于输液治疗和关键护理应用的创新医疗产品。ICU医疗产品组合包括IV智能泵，套装，连接器，危险药物，无菌IV解决方案，心脏监测系统的封闭系统转移装置，以及止痛管理和安全软件技术，旨在帮助满足临床，安全和工作流程。ICU Medical总部位于加利福尼亚州圣克莱门特。有关ICU Medical，Inc。的更多信息www.icumed.com.。